BIOHORIZONS INC.
Manufacturer adverse-event records for BIOHORIZONS INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2018–2026 · heavy-book · quiet Death-code · injury-heavy
Death-code intensity
BIOHORIZONS INC. is quieter on Death-coded events
Death-coded event_type rows are 0 of 41,891 (0.00% · quiet tercile among 443 manufacturers). Absolute volume is heavy-book.
What the Death-code reading shows for BIOHORIZONS INC.
The standout signal for BIOHORIZONS INC. is Death-code intensity: 0.00% of 41,891 reports (quiet tercile), while absolute volume is heavy-book.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair BIOHORIZONS INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 3 device types, led in this extract by Injury at 41,870 (99.9% of event_type total). Peak single-year volume reaches 20,087 reports across 4 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (3)
| Device | Reports |
|---|---|
| Implant, Endosseous, Root-Form | 41,874 |
| Abutment, Implant, Dental, Endosseous | 14 |
| Accessories, Implant, Dental, Endosseous | 3 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.